PDUFA VII: US FDA Wants Dedicated RMAT Program Funding

Gene Therapy for Cancer Treatment Concept Cancer therapy with T-cell and pipette and vials - Image
The increased cell and gene therapy workload forced CBER staff to limit sponsor interactions and convert live meetings to "written responses only" status. • Source: Shutterstock

More from User Fees

More from Pathways & Standards